Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer – a new role past lymphatics?

por Mesci, Aruz, Liu, Stanley K.
Publicado 2017

Spurious elevation of Prostate‐specific antigen associated with shingles in a prostate cancer patient undergoing active surveillance

por Mesci, Aruz, Liu, Stanley K., Loblaw, Douglas Andrew
Publicado 2018

Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer

por Gouran-Savadkoohi, Mohammad, Mesci, Aruz, Pond, Gregory R., Swaminath, Anand, Quan, Kimmen, Wright, Jim, Tsakiridis, Theodoros
Publicado 2023

Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis

por Mesci, Aruz, Huang, Xiaoyong, Taeb, Samira, Jahangiri, Sahar, Kim, Yohan, Fokas, Emmanouil, Bruce, Jeff, Leong, Hon S, Liu, Stanley K
Publicado 2017

RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer

por Mesci, Aruz, Lucien, Fabrice, Huang, Xiaoyong, Wang, Eric H., Shin, David, Meringer, Michelle, Hoey, Christianne, Ray, Jessica, Boutros, Paul C., Leong, Hon S., Liu, Stanley K.
Publicado 2019

(18)F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

por Mesci, Aruz, Ahmadi, Elham, Ali, Amr, Gouran-Savadkoohi, Mohammad, Evelyn Tsakiridis, Evangelia, Biziotis, Olga-Demetra, Chow, Tom, Kapoor, Anil, Sur, Monalisa, Steinberg, Gregory R., Liu, Stanley, Zukotynski, Katherine, Tsakiridis, Theodoros
Publicado 2023

Production of recombinant soluble dimeric C-type lectin-like receptors of rat natural killer cells

por Vaněk, Ondřej, Celadova, Petra, Skořepa, Ondřej, Bláha, Jan, Kalousková, Barbora, Dvorská, Anna, Poláchová, Edita, Pucholtová, Helena, Kavan, Daniel, Pompach, Petr, Hofbauerová, Kateřina, Kopecký, Vladimír, Mesci, Aruz, Voigt, Sebastian, Carlyle, James R.
Publicado 2019

Publisher Correction: Production of recombinant soluble dimeric C-type lectin-like receptors of rat natural killer cells

por Vaněk, Ondřej, Celadova, Petra, Skořepa, Ondřej, Bláha, Jan, Kalousková, Barbora, Dvorská, Anna, Poláchová, Edita, Pucholtová, Helena, Kavan, Daniel, Pompach, Petr, Hofbauerová, Kateřina, Kopecký, Vladimír, Mesci, Aruz, Voigt, Sebastian, Carlyle, James R.
Publicado 2020

Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses

por Tsakiridis, Evangelia E., Broadfield, Lindsay, Marcinko, Katarina, Biziotis, Olga-Demetra, Ali, Amr, Mekhaeil, Bassem, Ahmadi, Elham, Singh, Kanwaldeep, Mesci, Aruz, Zacharidis, Panayiotis G., Anagnostopoulos, Alexander E., Berg, Tobias, Muti, Paola, Steinberg, Gregory R., Tsakiridis, Theodoros
Publicado 2021

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

por Ali, Amr, Mekhaeil, Bassem, Biziotis, Olga-Demetra, Tsakiridis, Evangelia E., Ahmadi, Elham, Wu, Jianhan, Wang, Simon, Singh, Kanwaldeep, Menjolian, Gabe, Farrell, Thomas, Mesci, Aruz, Liu, Stanley, Berg, Tobias, Bramson, Jonathan L., Steinberg, Gregory R., Tsakiridis, Theodoros
Publicado 2023

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

por Biziotis, Olga‐Demetra, Tsakiridis, Evangelia Evelyn, Ali, Amr, Ahmadi, Elham, Wu, Jianhan, Wang, Simon, Mekhaeil, Bassem, Singh, Kanwaldeep, Menjolian, Gabe, Farrell, Thomas, Abdulkarim, Bassam, Sur, Ranjan K., Mesci, Aruz, Ellis, Peter, Berg, Tobias, Bramson, Jonathan L, Muti, Paola, Steinberg, Gregory R, Tsakiridis, Theodoros
Publicado 2023